- Home
- Companies
- usa florida
- autoimmune
Show results for
Refine by
Autoimmune Suppliers Serving Florida
141 companies found
based inIrvine, CALIFORNIA (USA)
We create the products and technologies that drive the advancement of aesthetic medicine. At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics brands and products. Our aesthetics portfolio ...
Patients receiving breast implants have reported a variety of systemic symptoms, such as joint pain, muscle aches, confusion, chronic fatigue, autoimmune diseases, and others. Individual patient risk for developing these symptoms ...
based inShanghai, CHINA
Henlius (2696.HK) is a global biopharmaceutical company with the vision to offer high-quality, affordable and innovative biologic medicines for patients worldwide with a focus on oncology, autoimmune diseases and ophthalmic diseases. Up to date, 5 ...
The Company's first product indicated for the treatment of autoimmune diseases. (adalimumab injection) was approved by the NMPA in December 2020. It is indicated for rheumatoid arthritis, ankylosing spondylitis, plaque psoriasis and ...
based inMarburg, GERMANY
DRG, founded in 1970, is a multinational specialty medical equipment and diagnostics manufacturer and distributor, with successful representation in over 110 countries through a network of DRG Subsidiaries and local distributors. The German ...
The DRG Anti Ovarian Ab ELISA is an enzyme immunoassay for the quantitative in vitro diagnostic measurement of antibodies directed against oocytes in human ...
based inMarcon, ITALY
BioTekna has independently designed, developed and produced all devices since 1996. The devices are connected to BioTekna's technological and scientific data centre BioTekna Plus, which is the core of the company. Device connectivity began in 2004 ...
Analysis, monitoring and biofeedback of the autonomic nervous system and the heart rate variability. Using multi-channel measurement plethysmograph technology applied to the distal ends of the limbs, the PPG Stress Flow medical device analysis the ...
based inSpringdale, ARKANSAS (USA)
ImmunoVision is proud to be a member of the Erba Diagnostics family, a part of the global ERBA Mannheim Group. Earlier known by the name of IVAX Diagnostics, the company specializes in manufacture and marketing of proprietary diagnostic reagents, ...
The ImmunoVision donor program has obtained disease state plasmas of various specificities. If we do not list the specificity that you need, please contact us at 479-751-7005. ImmunoVision is continually adding new and different monospecific donors ...
based inColleyville, TEXAS (USA)
Tennant Products makes therapeutic and performance grade nutraceuticals to give hope and empower. We are a family-owned and operated nutraceutical company that provides only the absolute highest quality ingredients available on the planet to ...
based inNewburypor, MASSACHUSETTS (USA)
At EnClear Therapies, our goal is to improve and extend the lives of patients with a wide variety of CNS disease through precision dosing. We are building an Integrated Neurotechnology Business using our CSF Health Platform to create a pipeline of ...
based inEl Cajon, CALIFORNIA (USA)
Calbiotech specializes in immunoassay development and manufacturing, with a comprehensive range of ELISA and CLIA assays for human and animal research, including specific assays for hormone, autoimmune disorders, cancer, infectious diseases and much ...
based inGaithersburg, MASSACHUSETTS (USA)
In November 2023, Selecta Biosciences Inc. (NASDAQ: SELB) merged with Cartesian Therapeutics to create a publicly traded company pioneering RNA cell therapy to treat autoimmune disease. The combined company will focus on advancing Cartesian’s wholly ...
Selecta Biosciences’ immune tolerance platform, ImmTOR, is designed to give rise to antigen-specific immunity, mitigating unwanted immune ...
based inWindsor, NOVA SCOTIA (CANADA)
BioMedica Diagnostics is a specialized company offering diagnostic solutions with a strong focus on Thrombosis and Haemostasis. The company collaborates globally with technology development firms and healthcare stakeholders to engineer and ...
based inRixensart, BELGIUM
CuraVac is a clinical-stage biotech company developing the medical and commercial potential of a revolutionary technique for the production of specific Therapeutic Vaccines for the treatment of autoimmune diseases. The company was founded by a ...
CuraVac is a clinical-stage biotechnology company developing the medical and commercial potential of a revolutionary technique for the production of specific Therapeutic Vaccines (or Active Targeted Immunotherapies) for autoimmune ...
based inStockholm, SWEDEN
Diamyd Medical is a clinical-stage diabetes company active in the field of pharmaceutical development. We develop two novel disease-modifying drugs: the antigenspecific immunotherapy Diamyd and the oral regenerative and immunomodulatory therapeutic ...
Diamyd® is a suspension for injection containing the active pharmaceutical ingredient GAD65 mixed with the vaccine adjuvant Alhydrogel (alum). The human recombinant protein GAD65 is manufactured in insect cells in a well-controlled GMP process. ...
based inVancouver, BRITISH COLUMBIA (CANADA)
Augurex develops biomarkers that transform patient clinical management for better disease outcomes by helping diagnose patients, whom when identified can be promptly treated. By biologically informing a clinical assessment, biomarkers optimize ...
14-3-3η is not normally present outside of cells. Therefore, in the disease state, the body views it as foreign and mounts an immune response in an attempt to clear it. This immune response generates14-3-3η specific auto-antibodies that are ...
based inDallas, TEXAS (USA)
Lupagen is a privately held early stage biotech company developing first-in-class bedside enabled cell & gene therapies (CAR-T cell, gene editing and immunotherapy products) based on their patent-pending bedside point-of-care C and GT production and ...
based inPlanegg, GERMANY
TQ Therapeutics GmbH is pioneering a novel approach to cell and gene therapy with its TQx platform, which transforms the production of cellular therapies into a rapid, automated process that occurs at the patient's side. This method leverages ...
TQx is developing a modular target cell-specific modification platform including relevant technology components for the generation of gene modified cell therapy ...
based inHercules, CALIFORNIA (USA)
Bio-Rad is a global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostic markets. With a focus on quality and customer service for over 65 years, our products ...
The BioPlex 2200 fully-automated, random access, multiplex testing platform uses sets of coated magnetic beads as the basis for a range of autoimmune, infectious disease, and other ...
based inPort Chester, NEW YORK (USA)
For over 25 years, OMNi-BiOTiC® has been a leading professional probiotic brand in Europe. In 2019, our dedicated team based in New York introduced Omni-Biotic to the United States. Our targeted Omni-Biotic blends developed for stress, immunity, ...
based inRapperswil, SWITZERLAND
Neovii is an independent, global biopharmaceutical company with a patient-focused mission to develop and bring to market novel life-transforming therapies to improve the outcomes in transplantation medicine, hemato-oncological and immune disorders. ...
In recent years, stem cell transplantation has also become an alternative therapeutic option for the treatment of other serious diseases, such as some autoimmune ...
based inGuidonia Montecelio, ITALY
Adaltis S.r.l. is an international IVD company headquartered in Rome, Italy. Adaltis develops, manufactures and markets in-vitro diagnostic systems and reagents to detect viral infections, diagnose immune system diseases and measure human hormone ...
based inHuningue, FRANCE
FIRALIS is a biotechnology company located in the very heart of BioValley, on the true triple border of FR-DE-CH, only a few minutes walking distance to Basel, the pharmaceutical capital of Europe. Firalis creates novel values via biomarker ...
As part of the European IMI BT-Cure consortium followed by the H2020 RABIOPRED program launched in 2016, FIRALIS launches its proprietary assay for the identification of markers related to inflammatory-autoimmune ...